TechCrunch

DECEMBER 16, 2022

“While it may feel counterintuitive, given the recent market environment, the value of the equity for all parties — investors, founders and employees — is higher in the more conservative growth scenario,” says Mitchem. 6 investors discuss why AI is more than just a buzzword in biotech. Target audience/market size slide.

Case Study 215

Case Study Biotech Survey Study 215

Crunchbase News

JANUARY 6, 2025

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 127

Marketing Company Technical Review Fintech 127

TechCrunch

AUGUST 25, 2021

In an increasingly hot biotech market, protecting IP is key. If you expect a return on investment, you can’t spend that kind of cash improving a niche crop for an outlier market. Nowadays, however, we have sequenced the genome of these plants and can be a little more direct.

Artificial Inteligence 246

Artificial Inteligence Machine Learning Study Biotech 246

Crunchbase News

JANUARY 7, 2025

Table of Contents Breakout year for AI Q4 push Large values, billion-dollar rounds US gained, Silicon Valley fired up Late-stage Q4 boom Early stage flat Seed settled Liquidity hold-up Methodology Glossary of funding terms Related reading Breakout year for AI One thing was clear: 2024 was the breakout year for funding to AI companies.

Artificial Intelligence 144

Artificial Intelligence Artificial Inteligence Report Technical Review 144

TechCrunch

NOVEMBER 22, 2022

million in a funding round led by Sequoia India and Southeast Asia’s Surge as it plans to expand the market for its medical imagery annotations solution. Artificial intelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificial intelligence in healthcare.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. The third advance involves machine learning to accelerate the process of turning optical data (the CD-style scanning signal) into usable data.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

NOVEMBER 22, 2024

Just as the holiday season begins, a sleighful of companies unveiled large funding rounds. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The $6 billion round valued the company at $24 billion post money.

Artificial Intelligence 120

Artificial Intelligence Artificial Inteligence Biotech Generative AI 120

TechCrunch

NOVEMBER 16, 2022

AI and proteins have been in the news lately, but largely because of the efforts of research outfits like DeepMind and Baker Lab. Their machine learning models take in easily collected RNA sequence data and predict the structure a protein will take — a step that used to take weeks and expensive special equipment.

Generative AI 206

Generative AI Artificial Inteligence Biotech Machine Learning 206

CIO

JULY 30, 2024

Many of the AI use cases entrenched in business today use older, more established forms of AI, such as machine learning, or don’t take advantage of the “generative” capabilities of AI to generate text, pictures, and other data. Marketing support Several AI experts and users point to marketing support as one of gen AI’s sweet spots.

Generative AI 216

Generative AI Artificial Inteligence Software Review Fractional CTO 216

TechCrunch

MARCH 17, 2023

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

JUNE 1, 2021

Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. The company leverages machine learning and a large body of knowledge about chemical reactions to create these processes, though as CSO Stanis?aw odarczyk-Pruszy?

Chemicals 246

Chemicals Artificial Inteligence Off-The-Shelf Machine Learning 246

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 119

Biotech Artificial Intelligence Artificial Inteligence Hotels 119

TechCrunch

JANUARY 25, 2022

Meanwhile, the company is developing machine learning algorithms with the ability to pick out subpar cells. . In an increasingly hot biotech market, protecting IP is key. She’ll plan to expand the machine learning capacity of the platform — a key part of making Cellino’s platform truly autonomous.

Machine Learning 246

Machine Learning Artificial Inteligence Biotech Study 246

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Sidecar Health believes a free-market approach will ensure healthcare is more accessible and affordable.

Artificial Inteligence 114

Artificial Inteligence Biotech Generative AI Healthcare 114

TechCrunch

JULY 16, 2022

Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. For instance, I loved hearing earlier this week about the launch of BigScience’s large language model , BLOOM , a free and open alternative to OpenAI’s GPT-3. It’s inspired by the daily TechCrunch+ column where it gets its name.

Artificial Inteligence 236

Artificial Inteligence Data Healthcare Trends 236

CIO

MAY 15, 2024

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” And with every passing day, “your guess is as good as mine” will become an increasingly uncomfortable answer.

Artificial Inteligence 195

Artificial Inteligence Generative AI Biotech Artificial Intelligence 195

Crunchbase News

AUGUST 9, 2024

billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. As the market tightened, seed-stage companies faced a more challenging environment in which to raise a Series A round. While total funding reached $31.5

Biotech 135

Biotech Artificial Intelligence Artificial Inteligence Healthcare 135

Crunchbase News

SEPTEMBER 13, 2024

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.

Biotech 75

Biotech Artificial Inteligence Artificial Intelligence Healthcare 75

Crunchbase News

OCTOBER 1, 2024

However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.

Biotech 117

Biotech Artificial Intelligence Artificial Inteligence Travel 117

Crunchbase News

JUNE 27, 2024

For the past few years the M&A market for startups has been slow — and the IPO pipeline nonexistent. However, just as AI is taking over venture, perhaps it is doing that for the M&A and IPO markets. Last week, artificial intelligence chips startup Cerebras Systems reportedly filed confidentially for an initial public offering.

Marketing 125

Marketing Artificial Intelligence Artificial Inteligence Biotech 125

Crunchbase News

FEBRUARY 28, 2025

After a couple of blistering weeks, large funding rounds slowed down to a crawl, with only two rounds hitting nine figures. Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year.

Biotech 75

Biotech Artificial Intelligence Artificial Inteligence Healthcare 75

N2Growth Blog

JANUARY 10, 2024

The life sciences industry is characterized by unique challenges and complexities, requiring leaders who deeply understand scientific advancements, regulatory frameworks, and highly dynamic market conditions.

Biotech 97

Biotech Leadership Recruiting Trends 97

Crunchbase News

AUGUST 2, 2024

Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio. The biotech uses AI-powered protein design to program immune cells battling tumors. The company also uses artificial intelligence to help members get care faster. The new round was led by Aliment Capital.

Biotech 121

Biotech Artificial Inteligence Artificial Intelligence Insurance 121

Crunchbase News

JUNE 7, 2024

Pika , $80M, artificial intelligence: It never takes us long to get to an AI startup on this list. Pika, an artificial intelligence startup that generates video, raised an $80 million round led by Spark Capital that values the Palo Alto, California-based company at $470 million, per Bloomberg.

Energy 123

Energy Biotech 3D Artificial Intelligence 123

Crunchbase News

JULY 2, 2024

Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. AlphaSense , $650M, artificial intelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.

Artificial Inteligence 125

Artificial Inteligence Biotech Software Review Healthcare 125

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. How and when to build marketing teams at deep tech companies. Longevica says it created a biotechnology platform for longevity after researching the life-span of laboratory mice.

Research 261

Research Biotech Nonprofit Comparison 261

TechCrunch

OCTOBER 5, 2021

Andiamo uses machine learning, 3D simulation and 3D printing to create custome braces for children with cerebral palsy, bringing down the cost and improving outcomes for clinicians, patients and families alike. Frontrunner combines sports betting with the flexibility of the stock market. departments.

Company 208

Company Meeting Sport 3D 208

TechCrunch

MARCH 16, 2023

A new story, also by Ivan , reports that Apple is reportedly experimenting with language-generating AI so that Siri can better understand queries. Staying power : 5 strategies for biotech startups to outlast a market downturn , as advised by James Coates. Christine has more. Alex found some bullish news for software companies.

Banking 249

Banking Biotech Report Artificial Intelligence 249

TechCrunch

SEPTEMBER 8, 2022

“In addition to DNA storage, Catalog has already discovered the means to incorporate DNA into algorithms and applications with potential widespread cases including artificial intelligence, machine learning, data analytics and secure computing.

Storage 206

Storage Artificial Inteligence Data Chemicals 206

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 123

Lambda Biotech Artificial Intelligence Artificial Inteligence 123

Crunchbase News

JULY 12, 2024

After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.

Biotech 118

Biotech Artificial Intelligence Artificial Inteligence Healthcare 118

TechCrunch

NOVEMBER 18, 2021

Therapeutic proteins, particularly monoclonal antibodies, are making up a bigger and bigger share of the drug market. Generate Biomedicines is focused on all protein modalities, but they have initially focused on developing antibodies, which Nally says make up about 60% of the protein-based biotherapeutics market. .

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

Crunchbase News

OCTOBER 18, 2024

Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures. Founded in 2021, the company has raised nearly $318 million, per Crunchbase.

Energy 112

Energy Artificial Inteligence Artificial Intelligence Biotech 112

Crunchbase News

JULY 10, 2024

North American startup funding perked up in the second quarter, bolstered by early-stage investment around artificial intelligence. Artificial intelligence remains the runaway favorite investment theme, as AI-focused startups pulled in $16.8 Overall, investors put $45.3 and Canadian startups in the second quarter of 2024.

Biotech 139

Biotech Artificial Intelligence Artificial Inteligence Report 139

TechCrunch

OCTOBER 6, 2022

France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem. But impact companies could still benefit from new processes, better network effects and more ambition in general.

Sustainability 188

Sustainability Programming Technical Review Biotech 188